Antipsychotic Adherence Intervention for Veterans over 40 with Schizophrenia: Results of a Pilot Study.
This pilot study tested the feasibility, acceptability, and effect-sizes of a multimodal, individual intervention designed to optimize antipsychotic medication use in patients >/=40 years of age with schizophrenia or schizoaffective disorder. METHODS: We randomized 40 patients into two groups: usual care (UC) or a nine-session, manualized, antipsychotic adherence intervention (AAI). The AAI attempted to improve adherence by combining three psychosocial techniques: a) education, b) skills training, and c) alliance building. Sessions employed a semi-structured format to facilitate open communication. The primary outcome was antipsychotic adherence at study end. We obtained qualitative data regarding patient preferences for the duration and modality for receiving the adherence intervention. RESULTS: Compared to the UC group, a greater proportion of the AAI group was adherent post-intervention (65% vs. 55.6%; OR=1.49), a difference that was statistically not significant. The entire AAI group reported that they intended to take medications, and 75% were satisfied with the intervention. CONCLUSIONS: The AAI was feasible and acceptable. Preliminary data on its effectiveness warrant a larger study. Qualitative data shows that patients prefer brief adherence interventions and accept telephone strategies.
Mittal
Dinesh
D
Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System, Department of Veterans Affairs (VA), Little Rock, Arkansas.
Owen
Richard R
RR
Lacro
Jonathan P
JP
D
Pharm
P
Landes
Reid D
RD
Edlund
Mark
M
Valenstein
Marcia
M
Jeste
Dilip V
DV
J Clin Psychiatry. 1999;60 Suppl 21:25-30
10548139
Schizophr Bull. 2006 Oct;32(4):724-42
16707778
J Clin Psychiatry. 2002 Oct;63(10):892-909
12416599
Drugs Aging. 2000 Nov;17(5):363-84
11190417
Am J Geriatr Psychiatry. 2003 Jan-Feb;11(1):17-23
12527536
Rev Saude Publica. 2000 Jun;34(3):280-5
10920451
N Engl J Med. 2005 Aug 4;353(5):487-97
16079372
Psychiatr Rehabil J. 2007 Summer;31(1):62-9
17694717
Am J Psychiatry. 1995 Jun;152(6):856-61
7755114
Psychiatr Serv. 1998 Feb;49(2):196-201
9575004
J Clin Psychiatry. 2001 May;62(5):394-9; quiz 400-1
11411825
Psychol Med. 1983 Feb;13(1):177-83
6133297
Schizophr Bull. 1995;21(3):419-29
7481573
Yakugaku Zasshi. 2001 Feb;121(2):187-90
11218734
Curr Pharm Des. 2004;10(18):2249-61
15281900
J Neuropsychiatry Clin Neurosci. 1993 Winter;5(1):56-60
8428136
Med Care. 2002 Aug;40(8):630-9
12187177
Schizophr Bull. 1987;13(2):261-76
3616518
Psychiatr Serv. 2001 Jun;52(6):805-11
11376229
Arch Gen Psychiatry. 1999 Sep;56(9):848-53
12884891
Br J Psychiatry. 1989 May;154:672-6
2574607
Acta Psychiatr Scand. 2003 Oct;108(4):297-303
12956831
J Psychosoc Nurs Ment Health Serv. 2007 Jun;45(6):29-37
17601158
Schizophr Bull. 1996;22(3):413-30
8873293
Br J Psychiatry Suppl. 1993 Dec;(22):39-44
8110442
Psychiatr Rehabil J. 2002 Summer;26(1):23-32
12171279
Schizophr Bull. 1997;23(4):637-51
9366000
Am J Psychiatry. 2004 Apr;161(4):692-9
15056516
Schizophr Bull. 2000;26(1):105-18
10755672
Psychiatr Serv. 1995 Nov;46(11):1161-5
8564506
Am J Psychiatry. 2002 Aug;159(8):1388-94
12153833
Can J Psychiatry. 1980 Dec;25(8):638-45
6110471
J Clin Psychiatry. 2007 Jul;68(7):992-7
17685733